We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2023
Programme
Mixed sites/palliation
12 May 2023 - 16 May 2023
Vienna, Austria
ESTRO 2023
Session
Mixed sites/palliation
Session Code:
6026
Session Type:
Poster (Digital)
Track:
Clinical
Add to
My Programme
Psychiatric comorbidity impact on radiotherapy and overall survival: a matched pair analysis.
Max Peters
,
The Netherlands
Presentation Number:
PO-1571
Recognition and treatment recommendations of oligometastasis in multidisciplinary tumor boards
Sebastian M. Christ
,
Switzerland
Presentation Number:
PO-1572
Oligometastatic prostate cancer: outcomes and toxicity of stereotactic body radiation therapy (SBRT)
Elias Gomis Selles
,
Spain
Presentation Number:
PO-1573
Sbrt boost following prior rt: toxicity results from a phase I dose escalation study (Destroy-1)
Donato Pezzulla
,
Italy
Presentation Number:
PO-1578
Association of upfront treatment and survival of SVC syndrome in advanced non-small cell lung cancer
Aniwat Berpan
,
USA
Presentation Number:
PO-1580
Can MR-guided HIFU replace palliative radiotherapy in the treatment of painful bone metastases?
Alice Zamagni
,
Italy
Presentation Number:
PO-1581
AI for Radiotherapy Auto-Contouring: Current Use, Perceptions of, and Barriers to Implementation
Sumeet Hindocha
,
United Kingdom
Presentation Number:
PO-1582
Need for relaxation techniques in patients undergoing radiotherapy - a single center interview
Rebecca Asadpour
,
Germany
Presentation Number:
PO-1583
Toxicity and clinical outcomes to abdominal radiotherapy using 5 fractions for non-surgical patients
RIE ASSO
,
Brazil
Presentation Number:
PO-1584
Stereotactic ablative radiotherapy (SABR) for multiple oligometastases: efficacy and safety
Ciro Franzese
,
Italy
Presentation Number:
PO-1585
Immunomodulation by partial tumor irradiation using and carbon-ions: bystander and abscopal effects
Slavisa Tubin
,
Austria
Presentation Number:
PO-1586
two years of ocular proton therapy in The Netherlands, clinical results
Coen Rasch
,
The Netherlands
Presentation Number:
PO-1587
Palliative care assessment in glioblastoma multiforme treated in a radiotherapy department.
Mercedes Gonzalez Cantero
,
Spain
Presentation Number:
PO-1588
Pentoxifylline and Vitamin E for radiation-induced fibrosis in breast and head and neck patients
Martin Harpsø
,
Denmark
Presentation Number:
PO-1591
A Phase I Study Evaluating the Safety of SCART for Bulky metastatic or recurrent Cancer
Weisi Yan
,
USA
Presentation Number:
PO-1592
Real-world electronic patient reported outcome utilization in patients receiving radiation therapy
Heather Curry
,
USA
Presentation Number:
PO-1593
Optimizing palliative radiotherapy treatment in last 30 days of life
Jose David González
,
Spain
Presentation Number:
PO-1594
Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases
Federica Ferrario
,
Italy
Presentation Number:
PO-1595
Stereotactic body re-irradiation for bone metastases
Laura Giannini
,
Italy
Presentation Number:
PO-1596
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia: Single Center Experience
Federico Colombo
,
Italy
Presentation Number:
PO-1597
SBRT WITH CDK4/6 INHIBITORS FOR OLIGORECURRENT/OLIGOPROGRESSIVE BREAST CANCER PATIENTS
Edy Ippolito
,
Italy
Presentation Number:
PO-1598
Survival prognosis of elderly patients irradiated for spinal bone metastases with a new scoring tool
Nils Nicolay
,
Germany
Presentation Number:
PO-1600
Hypofractionated dose-intensified palliative RT: 25 Gy in 5 fractions for enhanced symptom control
Jayson Paragas
,
Philippines
Presentation Number:
PO-1602
Radiation therapy for hypersalivation in patients with amyotrophic lateral sclerosis
Macarena M. Teja Ubach
,
Spain
Presentation Number:
PO-1603
Impact of COVID-19 pandemic in our Radiation oncology department
Patricia Valencia Nieto
,
Spain
Presentation Number:
PO-1604
Metastatic tumor burden in cancer patients: implications for the oligometastatic spectrum theory
Sebastian M. Christ
,
Switzerland
Presentation Number:
PO-1606
Same-day MRI-LINAC guided single fraction radiosurgery for painful non-spine bone metastases
Eva-Maria Kretschmer
,
Switzerland
Presentation Number:
PO-1607
SYNERGISTIC EFFECT OF STEREOTACTIC RADIOTHERAPY AND IMMUNOTHERAPY: AN ITALIAN MULTICENTRIC STUDY
Giuseppe Fanetti
,
Italy
Presentation Number:
PO-1608
Lung metastasis treatment with Stereotactic Body Radiation Therapy: a single institution experience
Susana Costa
,
Portugal
Presentation Number:
PO-1609
SBRT AS A RADICAL LOCAL TREATMENT IN OLIGOMETASTATIC DISEASE
Macarena M. Teja Ubach
,
Spain
Presentation Number:
PO-1610
PAROXYSMAL ATRIAL FIBRILLATION IN ELDERLY: LINAC-BASED SBRT ARRHYTHMIA RADIOABLATION PHASE 2 TRIAL
Alba Fiorentino
,
Italy
Presentation Number:
PO-1611
Inter and intrafraction motion in SABR patients treated for bone oligometastasis
Helen Hawes
,
United Kingdom
Presentation Number:
PO-1612
Is lumbosacral plexus delineation a must in modern pelvic radiotherapy ?
zineb DAHBI
,
Morocco
Presentation Number:
PO-1613
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.